Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach

Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic

Multicentric prospective study with collection of biological samples as part of type II research

Inclusion Criteria:

• Patient with cancer who will start treatment anticancer (see cohorts).
• Patient information and signature of the consent form before any specific procedure for the study. The patient must be able and must be inclined to cooperate in the study procedures.
• Patient affiliated to a social security scheme or beneficiary of a similar scheme.

Exclusion Criteria:

• Pregnant or lactating woman
• Patient under guardianship or curatorship or deprived of liberty by a decision judicial or administrative or patient unable to give his consent.